Advertisement

Monitoring Metabolite Gradients in the Blood, Liver, and Tumor after Induced Hyperglycemia in Rats with R3230 Flank Tumors Using Microdialysis and Bioluminescence Imaging

  • Cathryn Peltz
  • Thies Schroeder
  • Mark W. Dewhirst
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 566)

Abstract

Hypoxia is a common cause of reduced tumor response to treatment such as irradiation. The purpose of this study was to establish a method in a rat model that is clinically applicable to monitor the efficiency of glucose transport to both tumor and normal tissue following the induction of hyperglycemia. Female Fischer 344 rats bearing subcutaneous R3230 rat mammary adenocarcinomas received glucose (1 g/kg in 200 mg/ml Normosol) injected in the femoral vein with an infusion pump at a rate of 0.1 ml/min. Microdialysis sampling was performed on all animals. The perfusion marker Hoechst 33342 was injected intravenously at a dose of 5 mg/kg ten minutes prior to sacrifice. After the last blood sample was collected, the tumor and liver were removed and snap frozen for bioluminescence imaging and the rat was sacrificed. Imaging bioluminescence was performed on cryosections of the tumor and liver of the animal to monitor local metabolite gradients and concentrations of glucose in relation to the perfused vasculature, as determined by injected Hoechst 33342. Microdialysis and bioluminescence show comparable data when monitoring the changes of blood, liver, and tumor glucose concentrations as a result of induced hyperglycemia.

Keywords

Bioluminescence Imaging Microdialysis Sample Tumor Glucose Tumor Interstitial Fluid Blood Lactate Peak 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    M. Höckel, and P. Vaupel, Tumor hypoxia: definitions and current clinical, biologic and molecular aspects, J. Natl. Cancer Inst. 93(4), 266–276 (2001).PubMedCrossRefGoogle Scholar
  2. 2.
    H. G. Crabtree, Observations of the carbohydrate metabolism of tumors, Biochem. J. 23, 536–545 (1929).PubMedGoogle Scholar
  3. 3.
    S. A. Snyder, J. L. Lanzen, R. D. Braun, G. Rosner, T. W. Secomb, J. Biaglow, D. M. Brizel, and M. W. Dewhirst, Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone, Int. J. Radial. Oncol. Biol. Phys. 51(2), 494–506 (2001).CrossRefGoogle Scholar
  4. 4.
    S. N. Ettinger, C. C. Poellman, N. A. Wisniewski, A. A. Gaskin, J. S. Shoemaker, J. M. Poulson, M. W. Dewhirst, and B. Klitzman, Urea as a recovery maker for quantitative assessment of tumor interstitial solutes with microdialysis, Cancer Res. 61, 7964–7970 (2001).PubMedGoogle Scholar
  5. 5.
    S. Walenta, T. Schroeder, and W. Mueller-Klieser, Metabolic mapping with bioluminescence: basic and clinical relevance, Biomolec. Eng. 18, 249–262 (2002).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Cathryn Peltz
  • Thies Schroeder
  • Mark W. Dewhirst

There are no affiliations available

Personalised recommendations